methyl-prednisolonate and Sjogren-s-Syndrome

methyl-prednisolonate has been researched along with Sjogren-s-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for methyl-prednisolonate and Sjogren-s-Syndrome

Article	Year
Sjogren's thrombocytopenia. The Journal of the Association of Physicians of India, 2011, Volume: 59 Primary Sjogren's is a multisystem autoimmune disease which predominantly affects the exocrine glands. pSS may occasionally present in an atypical way which may defy correct diagnosis for a considerable period of time. Clinically important immune-mediated cytopenia (or a combination of cytopenias) may be the first manifestation of an occult SS and have only been rarely described with Sjogren's. This case exemplifies the atypical presentation of pSS and hence should be considered in the differential diagnosis of patients with unexplained cytopenias. Topics: Adult; Anemia, Hemolytic, Autoimmune; Antihypertensive Agents; Autoimmune Diseases; Female; Humans; Platelet Transfusion; Prednisolone; Pulse Therapy, Drug; Sjogren's Syndrome; Thrombocytopenia; Treatment Outcome	2011

Article

Year

The Journal of the Association of Physicians of India, 2011, Volume: 59

Primary Sjogren's is a multisystem autoimmune disease which predominantly affects the exocrine glands. pSS may occasionally present in an atypical way which may defy correct diagnosis for a considerable period of time. Clinically important immune-mediated cytopenia (or a combination of cytopenias) may be the first manifestation of an occult SS and have only been rarely described with Sjogren's. This case exemplifies the atypical presentation of pSS and hence should be considered in the differential diagnosis of patients with unexplained cytopenias.

Topics: Adult; Anemia, Hemolytic, Autoimmune; Antihypertensive Agents; Autoimmune Diseases; Female; Humans; Platelet Transfusion; Prednisolone; Pulse Therapy, Drug; Sjogren's Syndrome; Thrombocytopenia; Treatment Outcome

2011